Scientific Sessions 2024  /  GLP-1RAs and Beyond: Incretin Analogues and a New Frontier in Cardiovascular Therapeutics  /  Going with the FLOW: Understanding the renal effects of GLP-1RA therapy
Logo

American Heart Association

  2
  0

Final ID:

Going with the FLOW: Understanding the renal effects of GLP-1RA therapy

  • Tuttle, Katherine  ( PROVIDENCE MEDICAL RESEARCH CENTER , Spokane , Washington , United States )
  • Rangaswami, Janani  ( DC VA Medical Center , Washington , District of Columbia , United States )
    • Author Disclosures:
    Katherine Tuttle: DO have relevant financial relationships ; Consultant:Novo Nordisk:Active (exists now) ; Research Funding (PI or named investigator):Bayer:Past (completed) ; Research Funding (PI or named investigator):Travere:Active (exists now) ; Consultant:Pfizer:Past (completed) ; Consultant:Astra Zeneca:Past (completed) ; Consultant:ProKidney:Active (exists now) ; Consultant:Bayer:Active (exists now) ; Consultant:Eli Lilly and Company:Active (exists now) ; Consultant:Boehringer Ingelheim:Active (exists now) | Janani Rangaswami: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

GLP-1RAs and Beyond: Incretin Analogues and a New Frontier in Cardiovascular Therapeutics

Sunday, 11/17/2024 , 09:45AM - 11:00AM

Main Event

More abstracts on this topic:
Patient Interview

Ndumele Chiadi, Taub Pam

Panel Discussion

Powell-wiley Tiffany

More abstracts from these authors:
Interdisciplinary management for patients with Cardiovascular-Kidney-Metabolic Syndrome: Interactive Case Discussions

Rangaswami Janani, Pagidipati Neha

Panel Discussion

Tuttle Katherine

You have to be authorized to contact abstract author. Please, Login
Not Available